Withings Scan Monitor vs iPredict Eye Screening

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Withings
VS
by iHealthScreen

AI Verdict

Withings Scan Monitor provides direct physiological monitoring of cardiovascular health, such as AFib detection via ECG, and general wellness metrics through wearable devices for personal and remote patient monitoring. In contrast, iPredict Eye Screening primarily offers AI-powered screening for ophthalmic diseases like AMD and DR via retinal imaging, with an additional feature for systemic disease risk prediction, including stroke and heart attack. While both tools address aspects of cardiology and are relevant to internal medicine, their core methodologies and primary clinical applications are distinct.

Choose Withings Scan Monitor if…

Choose Withings Scan Monitor if you are an individual or a healthcare provider looking for a device-based solution for continuous or frequent personal health monitoring and remote patient monitoring. It excels in tracking cardiovascular health metrics like ECG for AFib, heart rate, and vascular age, alongside body composition and nerve health, directly from smart scales and smartwatches.

View Withings Scan Monitor →

Choose iPredict Eye Screening if…

Choose iPredict Eye Screening if you are a healthcare provider in a clinical setting requiring a fast, AI-powered screening tool for early detection of retinal diseases such as AMD, Diabetic Retinopathy, and Glaucoma. This cloud-based platform is ideal for integrating into primary care or ophthalmology workflows to quickly assess patient risk and also offers predictive insights for systemic conditions like stroke and heart attack.

View iPredict Eye Screening →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Withings Scan Monitor iPredict Eye Screening
Pricing Device purchase with optional subscription for enhanced features and clinical services. Contact for pricing
Deployment Device-based (smart scale, smartwatch) with cloud synchronization and mobile application. Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Withings Scan Monitor

Withings Scan Monitor (Tool A) offers a user-friendly experience for daily, at-home monitoring, with automatic user assignment and seamless data syncing to its well-designed mobile app. While some users find the amount of data extensive, its overall design prioritizes ease of integration into a patient's daily life.

Clinical Value

iPredict Eye Screening

iPredict Eye Screening (Tool B) provides highly specific and accurate AI-powered screening for critical eye diseases (AMD, DR, Glaucoma) with strong clinical validation and FDA clearance. Its innovative capability to predict systemic disease risks like stroke and heart attack from retinal images offers a unique and targeted diagnostic clinical value.

Pricing & Value

Withings Scan Monitor

Withings Scan Monitor (Tool A) offers transparent, consumer-facing pricing with a clear device purchase cost and an optional monthly subscription. In contrast, iPredict Eye Screening (Tool B) requires contacting for pricing, making its cost less transparent upfront, despite providing an estimated per-patient screening cost for clinics.

Enterprise Readiness

Withings Scan Monitor

Withings Scan Monitor (Tool A) demonstrates robust enterprise readiness with explicit BAA compliance, HIPAA certification, and comprehensive support for professional remote patient monitoring, including EHR integration, logistics, and flexible connectivity options for partners. Its 'Health Solutions' division provides dedicated support for enterprise clients.

Innovation

iPredict Eye Screening

iPredict Eye Screening (Tool B) stands out for its innovative AI-driven multi-disease eye screening and, more significantly, its ability to predict systemic disease risks like stroke and heart attack from retinal images. This represents a groundbreaking approach to linking ophthalmology with broader cardiovascular and neurological health.

Support & Docs

Tie

While Withings (Tool A) offers dedicated enterprise support and extensive online resources, its general customer service for individual users has received significant negative feedback. iHealthScreen (Tool B), as a B2B solution, would be expected to offer professional support, but specific details or documented user experiences for its enterprise support are not provided in the available information, making a definitive comparison challenging.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Withings Scan Monitor iPredict Eye Screening
Company Withings iHealthScreen
Primary Focus AI-powered ECG for AFib detection, heart rate, and other vital health metrics for personal use and remote patient monitoring. AI-powered screening for age-related macular degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma, with risk prediction for systemic diseases.
Key Health Metrics / Screenings 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan), Single-lead ECG for Atrial Fibrillation (AFib) detection (ScanWatch), Heart rate measurement and irregular rhythm notifications, Blood oxygen saturation (SpO2) measurement (ScanWatch), Vascular Age assessment (Body Scan), Nerve Health Score (Electrodermal Activity) (Body Scan), Segmental body composition analysis (Body Scan). AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma; Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients.
Target Specialties Cardiology, Internal Medicine Family Medicine, Internal Medicine, Ophthalmology

Videos

Demos, reviews, and walkthroughs featuring Withings Scan Monitor and iPredict Eye Screening.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Withings Scan Monitor is designed for cardiology and internal medicine, offering features like ECG for AFib detection, heart rate, and vascular age assessment. iPredict Eye Screening, on the other hand, focuses on ophthalmology, family medicine, and internal medicine, providing AI-powered screening for Diabetic Retinopathy, Age-related Macular Degeneration (specifically for patients aged 50 and older), and Glaucoma, along with systemic disease risk prediction.
The Withings Scan Monitor has FDA clearance for its ECG features for AFib detection, available in both 6-lead (Body Scan) and single-lead (ScanWatch) formats. iPredict Eye Screening is FDA-cleared for AI-powered screening of age-related macular degeneration (AMD) in patients aged 50 years and older, and also offers screening for Diabetic Retinopathy (DR) and Glaucoma.
Both tools state they are HIPAA compliant. The Withings Scan Monitor explicitly confirms it has a Business Associate Agreement (BAA). For iPredict Eye Screening, a BAA is not explicitly stated in the provided information.
The Withings Scan Monitor focuses on 6-lead/single-lead ECG for AFib detection, heart rate, blood oxygen saturation, vascular age assessment, nerve health score, and segmental body composition analysis. iPredict Eye Screening provides AI-based screening for Diabetic Retinopathy, Age-related Macular Degeneration, and Glaucoma, along with an online health risk prediction system for systemic diseases like stroke and heart attack.

Backers

Who funded each tool's parent company.

Withings Scan Monitor

AI Tool Finder
AI-powered search. Results may not be comprehensive.